Haojiang Dai
Impact in
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
-
- RNA modifications and cancer 3
- Ubiquitin and proteasome pathways 2
- Histone Deacetylase Inhibitors Research 1
- Surgery 3
- Co-authors
- Shusen Zheng (7 shared papers)Xiao Xu (5 shared papers)Haiyang Xie (6 shared papers)Qiaonan Shan (4 shared papers)Penghong Song (4 shared papers)Sunbin Ling (2 shared papers)Jie Li (1 shared paper)Lin Zhou (1 shared paper)
- Journals
- Molecular Oncology (1 paper)Scientific Reports (1 paper)Cancer Biomarkers (1 paper)Journal of Advanced Research (1 paper)BMC Cancer (1 paper)
- Partner nations
- ChinaMadagascarCanada
In The Last Decade
Haojiang Dai
9 papers receiving 313 citations
Peers
Comparison fields: 5 of 66
- Cancer Research 74
- Hepatology 37
- Molecular Biology 207
- Oncology 72
- Geriatrics and Gerontology 10
Countries citing papers authored by Haojiang Dai
This map shows the geographic impact of Haojiang Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haojiang Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haojiang Dai more than expected).
Fields of papers citing papers by Haojiang Dai
This network shows the impact of papers produced by Haojiang Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haojiang Dai. The network helps show where Haojiang Dai may publish in the future.
Co-authors
The 25 scholars most cited alongside Haojiang Dai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 99 | |
| 2 | 2017 | 84 | |
| 3 | 2017 | 61 | |
| 4 | 2024 | 22 | |
| 5 | 2016 | 19 | |
| 6 | 2017 | 16 | |
| 7 | 2022 | 6 | |
| 8 | 2020 | 6 | |
| 9 | 2025 | 2 |
About Haojiang Dai
Haojiang Dai is a scholar working on Molecular Biology, Surgery, Oncology, Hepatology and Cancer Research, having authored 9 papers that have together received 315 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (3 papers), RNA modifications and cancer (3 papers), Ubiquitin and proteasome pathways (2 papers), Hepatocellular Carcinoma Treatment and Prognosis (1 paper), Genetic and Kidney Cyst Diseases (1 paper), Cancer, Hypoxia, and Metabolism (1 paper), Histone Deacetylase Inhibitors Research (1 paper) and Supercapacitor Materials and Fabrication (1 paper). The work is most often cited by research in Cancer Research (74 citations), Hepatology (37 citations), Molecular Biology (207 citations), Oncology (72 citations) and Geriatrics and Gerontology (10 citations). Haojiang Dai has collaborated with scholars based in China, Madagascar and Canada. Frequent co-authors include Shusen Zheng, Xiao Xu, Haiyang Xie, Qiaonan Shan, Penghong Song, Sunbin Ling, Jie Li, Lin Zhou, Jun Chen and Zhikun Liu. Their work appears in journals such as Molecular Oncology, Scientific Reports, Cancer Biomarkers, Journal of Advanced Research and BMC Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.